Graham Julian Fraser-Pye

Aspire Pharma Holdings Ltd. is a holding British company founded in 2014. The private company is based in Godalming, UK. The company's subsidiaries market pharmaceutical products.

Part of Axonics, Inc., Axonics GmbH engages in the development, manufacture, and clinical application of hydrogels. The company is based in Ratingen, Germany. The German company was founded in 2000. Patrick John Banks has been the CEO of the company since 2010.

Contura Holdings Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in London, UK. The company was founded in 2016.

Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom.

Aphl 2 Ltd. is a British company that provides business support services. The private company is based in Godalming, UK. The company was founded in 2018.

APHL 1 Ltd. is a British company that provides business support services. The private company is based in Godalming, UK. The company was founded in 2018.

Contura International A/S develops and markets soft tissue fillers to the healthcare industry. Its products include Bulkamid, a class leading urethral bulking agent for treatment of stress urinary incontinence; and Aquamid, an aesthetic injectable volumiser. The company was founded on March 1, 2000 and is headquartered in Søborg, Denmark.

Part of H.I.G. Capital LLC, Aspire Pharma Ltd. is a British company that licenses and develops products with innovative formulations, value for money for payors, and reliable supply agreements. The private company is based in Petersfield, UK. Aspire Pharma is present in the generics, speciality generics, branded medicines, and medical device sectors. The company was founded in 2009 by Graham Julian Fraser-Pye. The CEO is Richard Michael Condon. Aspire Pharma was acquired by H.I.G. Capital LLC on September 24, 2021.